Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis
Abstract
:1. Introduction
2. Materials and Methods
2.1. Protocol and Search Strategy
2.2. Inclusion and Exclusion Criteria
2.3. Study Selection and Data Extraction
3. Results
3.1. Overview of the Search Process
3.2. Areca Nut
3.3. Pan Masala
3.4. Gutkha
3.5. BQ and BQ (Unspecified)
3.6. Stem Quid
3.7. Lao-Hwa
4. Discussion
Limitations of This Review
5. Conclusions and Future Directions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Pindborg, J.J.; Murti, P.R.; Bhonsle, R.B.; Gupta, P.C.; Daftary, D.K.; Mehta, F.S. Oral submucous fibrosis as a precancerous condition. Scand J. Dent. Res. 1984, 92, 224–229. [Google Scholar] [CrossRef] [PubMed]
- Shen, Y.W.; Shih, Y.H.; Fuh, L.J.; Shieh, T.M. Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments. Int. J. Mol. Sci. 2020, 21, 7231. [Google Scholar] [CrossRef] [PubMed]
- Jeng, J.H.; Chang, M.C.; Hahn, L.J. Role of areca nut in betel quid-associated chemical carcinogenesis: Current awareness and future perspectives. Oral Oncol. 2001, 37, 477–492. [Google Scholar] [CrossRef]
- Warnakulasuriya, S.; Johnson, N.W.; van der Waal, I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J. Oral Pathol. Med. 2007, 36, 575–580. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.Y.; Tail, Y.-H.; Wang, W.C.; Chen, C.Y.; Kao, Y.H.; Chen, Y.K.; Chen, C.H. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health 2014, 14, 99. [Google Scholar] [CrossRef] [PubMed]
- Kujan, O.; Mello, F.W.; Warnakulasuriya, S. Malignant transformation of oral submucous fibrosis: A systematic review and meta-analysis. Oral Dis. 2021, 27, 1936–1946. [Google Scholar] [CrossRef]
- Shih, Y.H.; Wang, T.H.; Shieh, T.M.; Tseng, Y.H. Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy. Int. J. Mol. Sci. 2019, 20, 2940. [Google Scholar] [CrossRef] [Green Version]
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-Quid and Areca-Nut Chewing and Some Areca-Nut Derived Nitrosamines; IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; IARC: Lyon, France, 2004; Volume 85, p. 1. [Google Scholar]
- World Health Organization. Review of Areca (Betel) Nut and Tobacco Use in the Pacific: A Technical Report; WHO Regional Office for the Western Pacific: Manila, Philippines, 2012. [Google Scholar]
- Kerr, A.R.; Warnakulasuriya, S.; Mighell, A.J.; Dietrich, T.; Nasser, M.; Rimal, J.; Jalil, A.; Bornstein, M.M.; Nagao, T.; Fortune, F.; et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis. 2011, 17 (Suppl. S1), 42–57. [Google Scholar] [CrossRef]
- Zhang, P.; Chua, N.Q.E.; Dang, S.; Davis, A.; Chong, K.W.; Prime, S.S.; Cirillo, N. Molecular Mechanisms of Malignant Transformation of Oral Submucous Fibrosis by Different Betel Quid Constituents—Does Fibroblast Senescence Play a Role? Int. J. Mol. Sci. 2022, 23, 1637. [Google Scholar] [CrossRef]
- Sari, E.F.; McCullough, M.; Cirillo, N. Oral pre-malignant and malignant lesion detection among indonesians; the prevalence and risk factors. Head Neck 2017, 39 (Suppl. S1), E58. [Google Scholar]
- Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Khan, A.; Ongole, R.; Baptist, J.; Srikant, N.; Lukmani, F. Patterns of Tobacco Use and its Relation to Oral Precancers and Cancers among Individuals Visiting a Tertiary Hospital in South India. J. Contemp Dent. Pract. 2020, 21, 304–309. [Google Scholar]
- Mehrotra, D.; Kumar, S.; Agarwal, G.G.; Asthana, A.; Kumar, S. Odds ratio of risk factors for oral submucous fibrosis in a case control model. Br. J. Oral Maxillofac. Surg. 2013, 51, e169–e173. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.H.; Ho, P.S.; Lu, H.M.; Huang, I.Y.; Chen, C.H. Comparing dose-response measurements of oral habits on oral leukoplakia and oral submucous fibrosis from a community screening program. J. Oral Pathol. Med. 2010, 39, 306–312. [Google Scholar] [CrossRef]
- Ariyawardana, A.; Athukorala, A.D.S.; Arulanandam, A. Effect of betel chewing, tobacco smoking and alcohol consumption on oral submucous fibrosis: A case-control study in Sri Lanka. J. Oral Pathol. Med. 2006, 35, 197–201. [Google Scholar] [CrossRef] [PubMed]
- Chung, C.H.; Yang, Y.H.; Wang, T.Y.; Shieh, T.Y.; Warnakulasuriya, S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J. Oral Pathol. Med. 2005, 34, 460–466. [Google Scholar] [CrossRef]
- Yang, Y.H.; Lien, Y.C.; Ho, P.S.; Chen, C.H.; Chang, J.S.F.; Cheng, T.C.; Shieh, T.Y. The effects of chewing areca/betel quid with and without cigarette smoking on oral submucous fibrosis and oral mucosal lesions. Oral Dis. 2005, 11, 88–94. [Google Scholar] [CrossRef]
- Jacob, B.J.; Straif, K.; Thomas, G.; Ramadas, K.; Mathew, B.; Zhang, Z.F.; Sankaranarayanan, R.; Hashibe, M. Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol. 2004, 40, 697–704. [Google Scholar] [CrossRef]
- Ranganathan, K.; Uma Devi, M.; Joshua, E.; Kirankumar, K.; Saraswathi, T.R. Oral submucous fibrosis: A case-control study in Chennai, South India. J. Oral Pathol. Med. 2004, 33, 274–277. [Google Scholar] [CrossRef]
- Lee, C.H.; Ko, Y.C.; Huang, H.L.; Chao, Y.Y.; Tsai, C.C.; Shieh, T.Y.; Lin, L.M. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br. J. Cancer 2003, 88, 366–372. [Google Scholar] [CrossRef] [Green Version]
- Hazare, V.K.; Goel, R.R.; Gupta, P.C. Oral submucous fibrosis, areca nut and pan masala use: A case-control study. Natl. Med. J. India 1998, 11, 299. [Google Scholar] [PubMed]
- Maher, R.; Lee, A.J.; Warnakulasuriya, K.A.; Lewis, J.A.; Johnson, N.W. Role of areca nut in the causation of oral submucous fibrosis: A case-control study in Pakistan. J. Oral Pathol. Med. 1994, 23, 65–69. [Google Scholar] [CrossRef] [PubMed]
- Niaz, K.; Maqbool, F.; Khan, F.; Bahadar, H.; Ismail Hassan, F.; Abdollahi, M. Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer. Epidemiol. Health 2017, 39, e2017009. [Google Scholar] [CrossRef] [PubMed]
- Aishwarya, K.M.; Reddy, M.P.; Kulkarni, S.; Doshi, D.; Reddy, B.S.; Satyanarayana, D. Effect of Frequency and Duration of Tobacco Use on Oral Mucosal Lesions—A Cross-Sectional Study among Tobacco Users in Hyderabad, India. Asian Pac. J. Cancer Prev. 2017, 18, 2233–2238. [Google Scholar] [PubMed]
- Li, W.C.; Lee, P.L.; Chou, I.C.; Chang, W.J.; Lin, S.C.; Chang, K.W. Molecular and cellular cues of diet-associated oral carcinogenesis—With an emphasis on areca-nut-induced oral cancer development. J. Oral Pathol. Med. 2015, 44, 167–177. [Google Scholar] [CrossRef] [PubMed]
- Sharma, D.C. Betel quid and areca nut are carcinogenic without tobacco. Lancet Oncol. 2003, 4, 587. [Google Scholar] [CrossRef]
- Tilakaratne, W.M.; Ekanayaka, R.P.; Warnakulasuriya, S. Oral submucous fibrosis: A historical perspective and a review on etiology and pathogenesis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016, 122, 178–191. [Google Scholar] [CrossRef] [Green Version]
- Lee, Y.-H.; Yang, L.-C.; Hu, F.-W.; Peng, C.-Y.; Yu, C.-H.; Yu, C.-C. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis. J. Formos. Med. Assoc. 2016, 115, 311–317. [Google Scholar] [CrossRef]
- Nair, U.; Bartsch, H.; Nair, J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: A review of agents and causative mechanisms. Mutagenesis 2004, 19, 251–262. [Google Scholar] [CrossRef] [Green Version]
- Nair, U.J.; Nair, J.; Friesen, M.D.; Bartsch, H.; Ohshima, H. Ortho- and meta-tyrosine formation from phenylalanine in human saliva as a marker of hydroxyl radical generation during betel quid chewing. Carcinogenesis 1995, 16, 1195–1198. [Google Scholar] [CrossRef]
- Shah, G.; Chaturvedi, P.; Vaishampayan, S. Arecanut as an emerging etiology of oral cancers in India. Indian J. Med. Paediatr Oncol. 2012, 33, 71–79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jayalakshmi, A.; Mathew, A.G. Chemical Composition and Processing; Bavappa, K.V.A., Nair, M.K., Prem Kumar, T., Eds.; The Arecanut Palm, Kerala, Central Plantation Crops Research Institute: Kasaragod, India, 1982; pp. 225–244. [Google Scholar]
- Prabhu, R.V.; Prabhu, V.; Chatra, L.; Shenai, P.; Suvarna, N.; Dandekeri, S. Areca nut and its role in oral submucous fibrosis. J. Clin Exp Dent. 2014, 6, e569–e575. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sari, E.F.; Prayogo, G.P.; Loo, Y.T.; Zhang, P.; McCullough, M.J.; Cirillo, N. Distinct phenolic, alkaloid and antioxidant profile in betel quids from four regions of Indonesia. Sci. Rep. 2020, 10, 16254. [Google Scholar] [CrossRef]
- Johnson, N.W.; Amarasinghe, H.K. Epidemiology and aetiology of head and neck cancers. In Head and Neck Cancer; Springer: Cham, Switzerland, 2016; pp. 1–57. [Google Scholar]
- Cheng, R.-H.; Wang, Y.-P.; Chang, J.Y.; Pan, Y.-H.; Chang, M.-C.; Jeng, J.-H. Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis. Int. J. Mol. Sci. 2020, 21, 8104. [Google Scholar] [CrossRef]
- León-González, A.J.; Auger, C.; Schini-Kerth, V.B. Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochem. Pharm. 2015, 98, 371–380. [Google Scholar] [CrossRef] [PubMed]
- Jeng, J.H.; Kuo, M.L.; Hahn, L.J.; Kuo, M.Y. Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J. Dent. Res. 1994, 73, 1043–1049. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Das, S.; Parida, R.; Sriram Sandeep, I.; Nayak, S.; Mohanty, S. Biotechnological intervention in betelvine (Piper betle L.): A review on recent advances and future prospects. Asian Pac. J. Trop. Med. 2016, 9, 938–946. [Google Scholar] [CrossRef] [Green Version]
- Bhide, S.V.; Zariwala, M.B.A.; Amonkar, A.J.; Azuine, M.A. Chemopreventive efficacy of a betel leaf extract against benzo[a]pyrene-induced forestomach tumors in mice. J. Ethnopharmacol. 1991, 34, 207–213. [Google Scholar] [CrossRef]
- Toprani, R.; Patel, D. Betel leaf: Revisiting the benefits of an ancient Indian herb. South Asian J. Cancer 2013, 2, 140–141. [Google Scholar] [CrossRef]
- Awang, M.N. Estimation of arecoline contents in commercial areca (betel) nuts and its relation to oral precancerous lesions. Singap. Med. J. 1986, 27, 317–320. [Google Scholar]
- Huang, J.L.; McLeish, M.J. High-performance liquid chromatographic determination of the alkaloids in betel nut. J. Chromatogr. A 1989, 475, 447–450. [Google Scholar] [CrossRef]
- Chuang, S.L.; Wang, C.P.; Chen, M.K.; Su, W.W.; Su, C.W.; Chen, S.L.; Chiu, S.Y.; Fann, J.C.; Yen, A.M. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program. Oral Oncol. 2018, 87, 58–63. [Google Scholar] [CrossRef] [PubMed]
- Mehrtash, H.; Duncan, K.; Parascandola, M.; David, A.; Gritz, E.R.; Gupta, P.C.; Mehrotra, R.; Amer Nordin, A.S.; Pearlman, P.C.; Warnakulasuriya, S.; et al. Defining a global research and policy agenda for betel quid and areca nut. Lancet Oncol. 2017, 18, e767–e775. [Google Scholar] [CrossRef]
- Lin, C.F.; Wang, J.D.; Chen, P.H.; Chang, S.J.; Yang, Y.H.; Ko, Y.C. Predictors of betel quid chewing behavior and cessation patterns in Taiwan aborigines. BMC Public Health 2006, 6, 271. [Google Scholar] [CrossRef] [Green Version]
- Kaur, J.; Rinkoo, A.V.; Gouda, H.N.; Prasad, V.; Pendse, R.N. Implementation of MPOWER Package in the South-East Asia Region: Evidence from the WHO Report on the Global Tobacco Epidemic (2009–2021). Asian Pac J. Cancer Prev. 2021, 22 (Suppl. S2), 71–80. [Google Scholar] [CrossRef]
Categories | Associated Terms |
---|---|
“BETEL QUID” | Betel OR masala OR lao-hwa OR gutkha OR tobacco OR paan masala OR betel mixture OR Piper betle stem OR Areca nut OR Betel quid OR Slaked lime OR Betel leaf OR Catechu OR Betel Inflorescence |
“ORAL SUBMUCOUS FIBROSIS” | Oral submucous fibrosis OR OPMD OR OSF OR OSMF OR premalignant lesion* OR premalignant condition* OR oral potentially malignant OR oral precancer* OR (idiopathic scleroderma of the mouth) OR juxtaepithelial fibrosis OR idiopathic palatal fibrosis OR sclerosing stomatitis |
Study Author/s (Year) | Study Population | Tobacco | Areca Nut | Betel Leaf | Slaked Lime | Other | Study Type | Region |
---|---|---|---|---|---|---|---|---|
Khan A et al. (2020) [14] | 1007 (n = 73 OSF) | X | X | X | X | Retrospective cohort | South India | |
Mehrotra D et al. (2013) [15] | 3136 (n = 448 OSF) | X | X | X | X | Catechu | Population-based case control study | Lucknow, India |
Yang YH et al. (2010) [16] | 2020 (n = 89 OSF) | X | X | X | X | Stem | Cross-sectional study | Taiwan |
Ariyawardana A et al. (2006) [17] | 148 (n = 74 OSF) | X | X | X | X | Cross-sectional study | Sri Lanka | |
Chung CH et al. (2005) [18] | 1075 (n = 17 OSF) | X | X | X | X | Cross-sectional study | Southern Taiwan | |
Yang YH et al. (2005) [19] | 102 (n = 62 OSF) | X | X | Case control study | Taiwan | |||
Jacob BJ et al. (2004) [20] | 49,085 (n = 170 OSF) | X | X | X | X | Case control study | Kerala, India | |
Ranganathan K et al. (2004) [21] | 370 (n = 185 OSF) | X | X | X | X | Case control study | Chennai, South India | |
Lee CH et al. (2003) [22] | 1095 (n = 94 OSF) | X | X | Betel inflor-escence | Case control study | Kaohsiung, Taiwan | ||
Hazare VK et al. (1998) [23] | 200 (all OSF) | X | Case control study | Nagpur, Maharash-tra | ||||
Maher R et al. (1994) [24] | 314 (n = 157 OSF) | X | X | X | Case control study | Karachi, Pakistan |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cirillo, N.; Duong, P.H.; Er, W.T.; Do, C.T.N.; De Silva, M.E.H.; Dong, Y.; Cheong, S.C.; Sari, E.F.; McCullough, M.J.; Zhang, P.; et al. Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis. Biomolecules 2022, 12, 664. https://doi.org/10.3390/biom12050664
Cirillo N, Duong PH, Er WT, Do CTN, De Silva MEH, Dong Y, Cheong SC, Sari EF, McCullough MJ, Zhang P, et al. Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis. Biomolecules. 2022; 12(5):664. https://doi.org/10.3390/biom12050664
Chicago/Turabian StyleCirillo, Nicola, Peter Hung Duong, Wee Teng Er, Casey Thao Nhi Do, Manikkuwadura Eranda Harshan De Silva, Yining Dong, Sok Ching Cheong, Elizabeth Fitriana Sari, Michael J. McCullough, Pangzhen Zhang, and et al. 2022. "Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis" Biomolecules 12, no. 5: 664. https://doi.org/10.3390/biom12050664
APA StyleCirillo, N., Duong, P. H., Er, W. T., Do, C. T. N., De Silva, M. E. H., Dong, Y., Cheong, S. C., Sari, E. F., McCullough, M. J., Zhang, P., & Prime, S. S. (2022). Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis. Biomolecules, 12(5), 664. https://doi.org/10.3390/biom12050664